# Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure

> **NCT01156207** · PHASE4 · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 120 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Aliskiren

## Key facts

- **NCT ID:** NCT01156207
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2013-07
- **Final completion:** —
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01156207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01156207, "Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01156207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*